Plasminogen Activator Inhibitor-1 and Tissue-Plasminogen Activator in Minority Adolescents with Type 2 Diabetes and Obesity
- 1 September 2005
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 58 (3) , 483-487
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Association between obesity and a prothrombotic state: the Framingham Offspring StudyThrombosis and Haemostasis, 2004
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Prospective study on plasma clotting parameters in diabetic children - no evidence for specific changes in coagulation systemExperimental and Clinical Endocrinology & Diabetes, 2001
- Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescentsMetabolism, 2000
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Infantile obesity: A situation of atherothrombotic risk?Metabolism, 2000
- American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart DiseaseCirculation, 1998
- Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II DiabetesDiabetes Care, 1994
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993
- Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988